Through structure-based virtual screening and biological evaluations, we have successfully identified several new Akt inhibitors that displayed cytotoxic activity against HCT-116 human colon cancer cells.
Compounds a46 and a48 may serve as useful lead compounds for further development of new anticancer agents.